Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation.
Peris I, Romero-Murillo S, Martínez-Balsalobre E, Farrington CC, Arriazu E, Marcotegui N, Jiménez-Muñoz M, Alburquerque-Prieto C, Torres-López A, Fresquet V, Martínez-Climent JA, Mateos MC, Cayuela ML, Narla G, Odero MD, Vicente C.
Peris I, et al. Among authors: cayuela ml.
Blood. 2023 Mar 2;141(9):1047-1059. doi: 10.1182/blood.2022016466.
Blood. 2023.
PMID: 36455198
Free PMC article.